AlphaRx Inc. Logo
AlphaRx Announces Completion of Phase II Clinical Trial for Indaflex
05 mars 2007 08h00 HE | AlphaRx Inc.
MARKHAM, Ontario, March 5, 2007 (PRIME NEWSWIRE) -- AlphaRx (OTCBB:ALRX) announced today the completion of the treatment phase of the double-blind, placebo & vehicle-controlled, randomized and...
AlphaRx Inc. Logo
AlphaRx's Nanoparticle Formulation of Antituberculosis Drug Shows Promise in Mice Infected With TB (Mycobacterium Tuberculosis)
20 févr. 2007 08h00 HE | AlphaRx Inc.
A leading Chinese TB research institute evaluated the efficacy of the Company's nanoparticle-encapsulated Streptomycin administered 2 times a week versus that of daily nonencapsulated drug...
AlphaRx Inc. Logo
AlphaRx Provides Positive Update On Indaflex
09 janv. 2007 10h45 HE | AlphaRx Inc.
MARKHAM, Ontario, Jan. 9, 2007 (PRIME NEWSWIRE) -- AlphaRx Inc. (OTCBB:ALRX) is pleased to announce that Proprius Pharmaceuticals Inc. has raised up to $17M in a Series A financing. A large portion of...
AlphaRx Inc. Logo
AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan in Hong Kong
08 mars 2006 08h00 HE | AlphaRx Inc.
MARKHAM, Ontario, March 8, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx Receives Notice of Allowance for U.S. Patent on Its Drug Delivery Platform
25 janv. 2006 08h00 HE | AlphaRx Inc.
MARKHAM, Ontario, Jan. 25, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx Updates Binoxan Development, a Potential Non-Irritating, Twice-a-Day Eye Drop for Ocular Inflammation
17 janv. 2006 08h00 HE | AlphaRx Inc.
MARKHAM, Ontario, Jan. 17, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx's Joint Venture Company Receives Marketing Approval for Flexogan Ultra in Hong Kong
10 janv. 2006 08h00 HE | AlphaRx Inc.
MARKHAM, Ontario, Jan. 10, 2006 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs,...
AlphaRx Inc. Logo
AlphaRx Launches Flexogan's First National TV Campaign with World Wrestling Entertainment
01 avr. 2004 08h30 HE | AlphaRx Inc.
RICHMOND HILL, Ontario, Canada, April 1, 2004 (PRIMEZONE) -- AlphaRx Inc. (OTCBB:ALRX) is launching its first Canadian national TV campaign with World Wrestling Entertainment Canada, Inc. to support...